LFST
Lifestance Health Group Inc
NASDAQ: LFST · HEALTHCARE · MEDICAL CARE FACILITIES
$7.43
-3.13% today
Updated 2026-04-29
Market cap
$2.88B
P/E ratio
371.50
P/S ratio
2.02x
EPS (TTM)
$0.02
Dividend yield
—
52W range
$4 – $8
Volume
2.5M
Lifestance Health Group Inc (LFST) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $212.52M | $377.22M | $667.51M | $859.54M | $1.06B | $1.25B | $1.42B |
| Revenue growth (YoY) | — | +77.5% | +77.0% | +28.8% | +22.8% | +18.5% | +13.9% |
| Cost of revenue | $150.12M | $242.90M | $466.00M | $622.52M | $753.57M | $848.57M | $1.02B |
| Gross profit | $62.40M | $134.32M | $201.51M | $237.02M | $302.10M | $402.40M | $406.35M |
| Gross margin | 29.4% | 35.6% | 30.2% | 27.6% | 28.6% | 32.2% | 28.5% |
| R&D | — | — | — | — | — | — | — |
| SG&A | $41.06M | $87.84M | $433.73M | $377.99M | $410.79M | $363.06M | $382.20M |
| Operating income | $15.24M | $15.44M | $-286.35M | $-210.17M | $-189.13M | $-31.61M | $25.71M |
| Operating margin | 7.2% | 4.1% | -42.9% | -24.5% | -17.9% | -2.5% | 1.8% |
| EBITDA | $21.34M | $8.77M | $-240.06M | $-143.60M | $-104.93M | $39.87M | $78.78M |
| EBITDA margin | 10.0% | 2.3% | -36.0% | -16.7% | -9.9% | 3.2% | 5.5% |
| EBIT | $15.24M | $-22.28M | $-294.19M | $-212.80M | $-185.36M | $-31.08M | $24.02M |
| Interest expense | $5.41M | $22.13M | $38.91M | $19.93M | $21.22M | $26.54M | $11.66M |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $5.67M | $-38.07M | $-307.20M | $-215.56M | $-186.26M | $-57.44M | $9.66M |
| Net income growth (YoY) | — | -771.5% | -706.9% | +29.8% | +13.6% | +69.2% | +116.8% |
| Profit margin | 2.7% | -10.1% | -46.0% | -25.1% | -17.6% | -4.6% | 0.7% |